Bank of New Hampshire’s Elevance Health ELV Stock Holding History

Bank of New Hampshire’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20	Closed	-$5.86K	–	545
2026 Q1	$5.86K	Hold	20	–	–	﹤0.01%	483
2025 Q4	$7.01K	Hold	20	–	–	﹤0.01%	420
2025 Q3	$6.46K	Sell	20 -50	-71%	-$15.6K	﹤0.01%	423
2025 Q2	$27.2K	Hold	70	–	–	0.01%	326
2025 Q1	$30.4K	Hold	70	–	–	0.01%	316
2024 Q4	$25.8K	Hold	70	–	–	0.01%	331
2024 Q3	$36.4K	Hold	70	–	–	0.01%	317
2024 Q2	$37.9K	Hold	70	–	–	0.01%	329
2024 Q1	$36.3K	Hold	70	–	–	0.01%	331
2023 Q4	$33K	Hold	70	–	–	0.01%	339
2023 Q3	$30.5K	Hold	70	–	–	0.01%	340
2023 Q2	$31.1K	Hold	70	–	–	0.01%	342
2023 Q1	$32.2K	Hold	70	–	–	0.01%	339
2022 Q4	$36K	Hold	70	–	–	0.01%	337
2022 Q3	$32K	Hold	70	–	–	0.01%	346
2022 Q2	$34K	Sell	70 -35	-33%	-$17.3K	0.01%	344
2022 Q1	$52K	Buy	+105	New	+$48K	0.01%	321

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New Hampshire's ELV Position: Q2 2026 in Review

Bank of New Hampshire sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 20 shares — an estimated $5.86K sold.

Bank of New Hampshire first reported a position in ELV in Q1 2022 and held it in 17 quarters. The position peaked at $52K in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Bank of New Hampshire reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Bank of New Hampshire sold 20 Elevance Health shares in Q2 2026, an estimated $5.86K.
Bank of New Hampshire first reported a position in Elevance Health in Q1 2022 and held it in 17 quarters.
Bank of New Hampshire's Elevance Health position peaked at $52K in Q1 2022.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.